Therapeutic cytodifferentiation in alveolar rhabdomyosarcoma without genetic change of the PAX3-FKHR chimeric fusion gene: a case study.

about

Therapeutic cytodifferentiation in alveolar rhabdomyosarcoma without genetic change of the PAX3-FKHR chimeric fusion gene: a case study.

Item

http://www.wikidata.org/entity/Q45895047

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Therapeutic cytodifferentiatio ...... ic fusion gene: a case study.

@en

Therapeutic cytodifferentiatio ...... ic fusion gene: a case study.

@nl

type

Item

label

Therapeutic cytodifferentiatio ...... ic fusion gene: a case study.

@en

Therapeutic cytodifferentiatio ...... ic fusion gene: a case study.

@nl

prefLabel

Therapeutic cytodifferentiatio ...... ic fusion gene: a case study.

@en

Therapeutic cytodifferentiatio ...... ic fusion gene: a case study.

@nl

P1476

Therapeutic cytodifferentiatio ...... ic fusion gene: a case study.

@en

P2093

Atsushi Kikuta

http://www.w3.org/2001/XMLSchema#string

Hiroshi Hojo

http://www.w3.org/2001/XMLSchema#string

Hitoshi Yamada

http://www.w3.org/2001/XMLSchema#string

Masafumi Abe

http://www.w3.org/2001/XMLSchema#string

Michiyuki Hakozaki

http://www.w3.org/2001/XMLSchema#string

Shinichi Kikuchi

http://www.w3.org/2001/XMLSchema#string

Shinichi Konno

http://www.w3.org/2001/XMLSchema#string

Takahiro Tajino

http://www.w3.org/2001/XMLSchema#string

P2860

Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations.

Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.

Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.

Pathologic classification of rhabdomyosarcomas and correlations with molecular studies.

Pax3 inhibits myogenic differentiation of cultured myoblast cells.

Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study.

Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.

Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.

cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.

Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature.

P2888

s13577-013-0067-6

P304

149-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13577-013-0067-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034867107

http://www.w3.org/2001/XMLSchema#string

P698

23797277

http://www.w3.org/2001/XMLSchema#string